Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

The Coronavirus Is Testing Tech Stocks in a Big Way

The coronavirus is making home offices great again, and may give tech stocks a big boost after the crisis has passed.

Is JD Stock a Solid Buy After Reaching Stability?

JD.com had an impressive Christmas quarter and seems to have gotten through the coronavirus unscathed. That could make it an outlier, or it could mean there is less to fear here than meets the eye

Advanced Micro Devices Stock Will Survive the Downturn

AMD stock is expensive with high price-earnings ratios, but analysts say it's worth the price, so let the buyer beware.

VMWare Stock Had Real Risks Even Before the Dip

VMWare stock looks attractive after a 30% plunge year-to-date. But risks loom, and investors bottom-fishing in tech might look elsewhere.

Wells Fargo Struggles to Keep Its Scandals in the Past

Wells Fargo is still working to put its years of scandals firmly in the past. WFC stock is struggling, but it won't be forever.

iBio Stock Is Unlikely a Coronavirus Winner and Thus a Real Gamble

IBIO stock is a big winner today thanks to the rapidly spreading coronavirus outbreak, but the longevity of this rally is at question.

Ford Needs to Give Investors a Reason to Own Ford Stock

After a historic market rout, there's no denying that F stock is cheap. But if that's the only thing going for it, Ford has a problem.

Here’s Why Alibaba Stock is Considered a Top Shelter From the Storm

In the face of global volatility and turmoil, Alibaba stock remains one of the best "shelter from the storm" names to own throughout and after the crisis.

Adobe Earnings: ADBE Stock Dips Slightly After Releasing Q1 Results

Adobe (ADBE) earnings report for the software company's fiscal first quarter of 2020 have ADBE stock heading down after-hours Thursday.

GAP Earnings: GPS Stock Jumps 2% After Beating Q4 Estimates

GAP (GPS) earnings for the clothing retail company's fiscal fourth quarter of 2019 have GPS stock up after-hours Thursday.

Ulta Earnings: ULTA Stock Dips 2% on Mixed Q4 Results, Guidance

Ulta (ULTA) earnings for the beauty products retailer's fiscal fourth quarter of 2019 have ULTA stock dipping lower after-hours Thursday.

Broadcom Earnings: AVGO Stock Drops 9% on Poor Q1 Performance

Broadcom (AVGO) earnings for the semiconductor company's fiscal first quarter of 2020 have AVGO stock taking a beating after-hours Thursday.

Slack Earnings: WORK Stock Falls 21% Despite Beating Q4 Estimates

Slack (WORK) earnings for the communications company's fiscal fourth quarter of 2020 have WORK stock taking a beating after-hours Thursday.

Oracle Earnings: ORCL Stock Heading 4% Higher on Q3 Beat

Oracle (ORCL) earnings for the computer tech company's fiscal third quarter of 2020 have ORCL stock up after-hours Thursday.

Dollar General Earnings: Market Chaos Crushing DG Stock Despite Beats

Dollar General earnings for the company's fourth quarter of 2019 were promising, but the broader market tumult is crushing DG stock.

Keep Calm And Don’t Trade TTD Stock Just Yet

Longer-term TTD stock has a lot going for it, but as a growth stock upstart a less-fit market environment demands patience rather than purchasing.

Aphria Needs Strong Sales Growth to Rise High Again

What does the future look like for Aphria stock? It depends on its success in growing market share and international sales.

Why iBio Pharma Stock Is Not for Timid Investors Despite Great Potential

Unless there are positive updates regarding a potential coronavirus vaccine soon, the run for new highs may be over in IBIO stock for now.

Pfizer Stock Remains a Cautionary Tale For Investors

Pfizer has seriously underperformed in recent years. Down 10.8% year to date, Pfizer stock remains an underdog.